09:44 AM EST - Immunovaccine Inc. : Has formed an inaugural Scientific and Clinical Advisory Committee comprised of academic and industry experts in disease areas in which Immunovaccine focuses: immuno-oncology and virology. Immunovaccine Inc.
shares T.IMV are trading unchanged at $1.19.
